FDA Inspection 1249424 — Hye Jin Choi, M.D., Ph.D.
The FDA completed an inspection of Hye Jin Choi, M.D., Ph.D. on Jul 25, 2024 in Seodaemun District. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 25, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Seodaemun District (Korea (the Republic of))
Additional Details
Clinical Investigator (CI)